| NCT04435743 |
Efficacy and Safety of Lenalidomide With or Without Rituximab and Other Drugs in B-cell Non-Hodgkin’s Lymphomas |
https://ClinicalTrials.gov/show/NCT04435743 |
Recruiting |
Ruijin Hospital |
2022-12-31 |
| NCT04434833 |
A Single-cell Transcriptome Study in Patients With Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT04434833 |
Recruiting |
Ruijin Hospital |
2022-06-30 |
| NCT03211702 |
Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2) |
https://ClinicalTrials.gov/show/NCT03211702 |
Active, not recruiting |
Chonbuk National University Hospital |
2018-04-30 |
| NCT03816683 |
A Disease Registry of Patients With Mantle Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03816683 |
Recruiting |
AstraZeneca |
2024-04-30 |
| NCT03546894 |
A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors |
https://ClinicalTrials.gov/show/NCT03546894 |
Recruiting |
Takeda |
2023-10-31 |
| NCT03375619 |
Long-term Follow-up Study of Patients Receiving CAR-20/19-T Cells |
https://ClinicalTrials.gov/show/NCT03375619 |
Recruiting |
Medical College of Wisconsin |
2020-08-01 |
| NCT03374137 |
Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03374137 |
Recruiting |
Hoffmann-La Roche |
2020-09-30 |
| NCT00899015 |
Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J |
https://ClinicalTrials.gov/show/NCT00899015 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03361358 |
Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT03361358 |
Completed |
Agios Pharmaceuticals, Inc. |
2019-09-30 |
| NCT03361020 |
Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation |
https://ClinicalTrials.gov/show/NCT03361020 |
Recruiting |
St. Jude Children’s Research Hospital |
2023-02-28 |
| NCT03342586 |
Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity |
https://ClinicalTrials.gov/show/NCT03342586 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-11-07 |
| NCT03327571 |
B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes |
https://ClinicalTrials.gov/show/NCT03327571 |
Completed |
Takeda |
2019-10-31 |
| NCT03323541 |
Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure |
https://ClinicalTrials.gov/show/NCT03323541 |
Completed |
University Hospital, Brest |
2016-12-31 |
| NCT03297697 |
Minimal Residual Disease in Peripheral T-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03297697 |
Active, not recruiting |
Washington University School of Medicine |
2021-07-31 |
| NCT03289182 |
An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin’s Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) |
https://ClinicalTrials.gov/show/NCT03289182 |
Active, not recruiting |
Hoffmann-La Roche |
2020-10-26 |
| NCT03260101 |
Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study |
https://ClinicalTrials.gov/show/NCT03260101 |
Recruiting |
Cellect Biotechnology |
2021-12-31 |
| NCT03226704 |
Leukapheresis for CAR-Therapy Manufacturing |
https://ClinicalTrials.gov/show/NCT03226704 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-05-01 |
| NCT03200977 |
Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab |
https://ClinicalTrials.gov/show/NCT03200977 |
Recruiting |
Bristol-Myers Squibb |
2022-12-30 |
| NCT03098589 |
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) |
https://ClinicalTrials.gov/show/NCT03098589 |
Recruiting |
Celgene |
2021-10-02 |
| NCT03104478 |
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL) |
https://ClinicalTrials.gov/show/NCT03104478 |
Recruiting |
The Lymphoma Academic Research Organisation |
2020-12-31 |
| NCT03079544 |
Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients |
https://ClinicalTrials.gov/show/NCT03079544 |
Recruiting |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2022-12-30 |
| NCT03053024 |
Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants |
https://ClinicalTrials.gov/show/NCT03053024 |
Completed |
Xian-Janssen Pharmaceutical Ltd. |
2019-09-30 |
| NCT03054883 |
Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy |
https://ClinicalTrials.gov/show/NCT03054883 |
Completed |
Czech Lymphoma Study Group |
2015-12-31 |
| NCT03040206 |
Risk Stratification of Nodal PTCL |
https://ClinicalTrials.gov/show/NCT03040206 |
Completed |
Chonbuk National University Hospital |
2017-06-30 |
| NCT03042247 |
Prospective Comparison Between FDG-PET/MR and FDG-PET/CT in Classical Hodgkin Lymphoma and DLBC Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT03042247 |
Recruiting |
Federico II University |
2020-06-10 |
| NCT03037177 |
Mediastinal Grey Zone Lymphoma From the LYSA |
https://ClinicalTrials.gov/show/NCT03037177 |
Completed |
Hospices Civils de Lyon |
2016-01-31 |
| NCT03000192 |
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life |
https://ClinicalTrials.gov/show/NCT03000192 |
Active, not recruiting |
University Hospital Southampton NHS Foundation Trust |
2020-12-31 |
| NCT02992223 |
Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT |
https://ClinicalTrials.gov/show/NCT02992223 |
Completed |
Azienda Ospedaliera Città della Salute e della Scienza di Torino |
2015-07-31 |
| NCT02978898 |
CD180 Overexpression in Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT02978898 |
Completed |
Hospices Civils de Lyon |
2014-06-30 |
| NCT02951871 |
Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis |
https://ClinicalTrials.gov/show/NCT02951871 |
Completed |
Hospices Civils de Lyon |
2016-01-31 |
| NCT02945319 |
Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma |
https://ClinicalTrials.gov/show/NCT02945319 |
Active, not recruiting |
International Extranodal Lymphoma Study Group (IELSG) |
2020-06-30 |
| NCT02904577 |
Indolent Non Follicular Lymphomas Prognostic Project |
https://ClinicalTrials.gov/show/NCT02904577 |
Active, not recruiting |
Fondazione Italiana Linfomi ONLUS |
2024-09-30 |
| NCT02108444 |
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT02108444 |
Completed |
Peking University |
2013-12-31 |
| NCT02848274 |
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome |
https://ClinicalTrials.gov/show/NCT02848274 |
Recruiting |
Stanford University |
2022-03-31 |
| NCT02840747 |
Tissue Repository: CTCL Collection Protocol |
https://ClinicalTrials.gov/show/NCT02840747 |
Recruiting |
Columbia University |
2021-01-31 |
| NCT02823327 |
Clinical Factors and Gene Expression Analysis for Prognosis in Tissue Samples From Patients With AIDS-Related Primary Effusion Lymphoma |
https://ClinicalTrials.gov/show/NCT02823327 |
Recruiting |
AIDS Malignancy Consortium |
2020-12-31 |
| NCT02795013 |
Genetic Study of Families With High Frequency of Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT02795013 |
Completed |
St. Jude Children’s Research Hospital |
2018-02-27 |
| NCT02788916 |
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas |
https://ClinicalTrials.gov/show/NCT02788916 |
Completed |
Takeda |
2016-11-10 |
| NCT02708732 |
Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL) |
https://ClinicalTrials.gov/show/NCT02708732 |
Completed |
Hoffmann-La Roche |
2016-10-31 |
| NCT02655744 |
Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute |
https://ClinicalTrials.gov/show/NCT02655744 |
Recruiting |
Chang Gung Memorial Hospital |
2022-12-31 |
| NCT02633111 |
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas |
https://ClinicalTrials.gov/show/NCT02633111 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-10-31 |
| NCT02589548 |
Brazilian Prospective Hodgkin Lymphoma Registry |
https://ClinicalTrials.gov/show/NCT02589548 |
Recruiting |
Universidade Federal do Rio de Janeiro |
2020-12-31 |
| NCT01676805 |
Tissue Collection for Studies of Lymph Cancer |
https://ClinicalTrials.gov/show/NCT01676805 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00923442 |
Biology Studies of Hematologic Cancers |
https://ClinicalTrials.gov/show/NCT00923442 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01351545 |
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) |
https://ClinicalTrials.gov/show/NCT01351545 |
Recruiting |
Center for International Blood and Marrow Transplant Research |
2021-10-31 |
| NCT02559583 |
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin’s Lymphoma (NHL) in Latin America |
https://ClinicalTrials.gov/show/NCT02559583 |
Completed |
Janssen-Cilag Ltd. |
2016-06-30 |
| NCT02555267 |
Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT02555267 |
Active, not recruiting |
Chonbuk National University Hospital |
2017-07-31 |
| NCT02536664 |
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants |
https://ClinicalTrials.gov/show/NCT02536664 |
Completed |
Hoffmann-La Roche |
2014-06-30 |
| NCT02520895 |
Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02520895 |
Completed |
Hospices Civils de Lyon |
2013-10-31 |
| NCT02520908 |
Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis |
https://ClinicalTrials.gov/show/NCT02520908 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-09-30 |
| NCT02504190 |
Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM) |
https://ClinicalTrials.gov/show/NCT02504190 |
Completed |
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation |
2019-11-30 |
| NCT03571997 |
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma |
https://ClinicalTrials.gov/show/NCT03571997 |
Recruiting |
PETHEMA Foundation |
2020-09-01 |
| NCT02486952 |
MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT02486952 |
Completed |
Hoffmann-La Roche |
2011-01-31 |
| NCT02476734 |
FDG-PET/CT Imaging as Early Predictor of DP |
https://ClinicalTrials.gov/show/NCT02476734 |
Completed |
University of Pennsylvania |
2016-02-29 |
| NCT02472756 |
A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT02472756 |
Completed |
Hoffmann-La Roche |
2014-05-30 |
| NCT02474160 |
Collection and Storage of Tissue and Blood Samples From Patients With Cancer |
https://ClinicalTrials.gov/show/NCT02474160 |
Recruiting |
National Cancer Institute (NCI) |
2021-05-04 |
| NCT02461290 |
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1 |
https://ClinicalTrials.gov/show/NCT02461290 |
Completed |
Hoffmann-La Roche |
2013-11-30 |
| NCT02404818 |
Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy |
https://ClinicalTrials.gov/show/NCT02404818 |
Active, not recruiting |
University of Florida |
2022-04-30 |
| NCT02386813 |
International Extranodal NK/T-cell Lymphoma Project |
https://ClinicalTrials.gov/show/NCT02386813 |
Completed |
Samsung Medical Center |
2015-06-30 |
| NCT02370446 |
Testing a Personalize Medication Log for Patients With Lymphoma |
https://ClinicalTrials.gov/show/NCT02370446 |
Completed |
Memorial Sloan Kettering Cancer Center |
2017-01-31 |
| NCT02364050 |
Prospective Data Collection of Elderly Patients With DLBCL Receiving at the Time of Diagnosis VGM |
https://ClinicalTrials.gov/show/NCT02364050 |
Active, not recruiting |
Fondazione Italiana Linfomi ONLUS |
2017-12-31 |
| NCT02354846 |
An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study) |
https://ClinicalTrials.gov/show/NCT02354846 |
Recruiting |
Yonsei University |
2021-03-31 |
| NCT02341781 |
Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment |
https://ClinicalTrials.gov/show/NCT02341781 |
Completed |
Celgene |
2016-09-30 |
| NCT02316613 |
Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE) |
https://ClinicalTrials.gov/show/NCT02316613 |
Completed |
Hoffmann-La Roche |
2013-04-30 |
| NCT02300402 |
Detection and Characterization of Residual Masses in Lymphomas |
https://ClinicalTrials.gov/show/NCT02300402 |
Recruiting |
The Lymphoma Academic Research Organisation |
2020-12-31 |
| NCT02240316 |
An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical Practice |
https://ClinicalTrials.gov/show/NCT02240316 |
Completed |
Hoffmann-La Roche |
2019-07-22 |
| NCT02199288 |
Effectiveness, Safety & Nurse Management Study of MabThera SC in Patients With Non-Hodgkin’s Lymphoma: Real-Life Setting |
https://ClinicalTrials.gov/show/NCT02199288 |
Completed |
Hoffmann-La Roche |
2016-07-31 |
| NCT02139592 |
Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) “Relapsed or Refractory CD30+ Hodgkin’s Lymphoma or Anaplastic Large Cell Lymphoma” |
https://ClinicalTrials.gov/show/NCT02139592 |
Completed |
Takeda |
2017-06-30 |
| NCT02106611 |
Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors |
https://ClinicalTrials.gov/show/NCT02106611 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-04-30 |
| NCT02072967 |
Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT02072967 |
Completed |
Astellas Pharma Inc |
2015-10-31 |
| NCT02069639 |
TARC After alloSCT in Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT02069639 |
Completed |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2014-01-31 |
| NCT02060435 |
Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT02060435 |
Completed |
Samsung Medical Center |
2013-12-31 |
| NCT01311232 |
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab |
https://ClinicalTrials.gov/show/NCT01311232 |
Completed |
Samsung Medical Center |
2012-12-01 |
| NCT01287923 |
Assessment of Blood Biomarkers by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans |
https://ClinicalTrials.gov/show/NCT01287923 |
Completed |
Rennes University Hospital |
2017-06-08 |
| NCT03190928 |
Clonal Evolution in Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT03190928 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-07-01 |
| NCT03356678 |
Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03356678 |
Completed |
Samsung Medical Center |
2017-06-30 |
| NCT01941680 |
High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant |
https://ClinicalTrials.gov/show/NCT01941680 |
Active, not recruiting |
University Hospital Center of Martinique |
2018-02-28 |
| NCT01820117 |
Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation |
https://ClinicalTrials.gov/show/NCT01820117 |
Completed |
St. Jude Children’s Research Hospital |
2018-02-20 |
| NCT01809600 |
Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt’s or Burkitt-like Lymphoma in Adults |
https://ClinicalTrials.gov/show/NCT01809600 |
Completed |
Gachon University Gil Medical Center |
2014-03-31 |
| NCT01793233 |
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas |
https://ClinicalTrials.gov/show/NCT01793233 |
Active, not recruiting |
Children’s Oncology Group |
2020-12-31 |
| NCT01790152 |
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment |
https://ClinicalTrials.gov/show/NCT01790152 |
Recruiting |
Children’s Oncology Group |
2022-03-30 |
| NCT01788839 |
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma |
https://ClinicalTrials.gov/show/NCT01788839 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-28 |
| NCT01789060 |
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma |
https://ClinicalTrials.gov/show/NCT01789060 |
Completed |
Samsung Medical Center |
2013-02-28 |
| NCT01731379 |
Optical Detection of Peripheral Nerve Bundles During Surgery |
https://ClinicalTrials.gov/show/NCT01731379 |
Completed |
Philips Healthcare |
2014-01-31 |
| NCT04150328 |
Lenalidomide Monotherapy in R/R DLBCL |
https://ClinicalTrials.gov/show/NCT04150328 |
Recruiting |
MorphoSys AG |
2019-08-29 |
| NCT01684865 |
An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT01684865 |
Completed |
Hoffmann-La Roche |
2017-11-27 |
| NCT01664936 |
Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes |
https://ClinicalTrials.gov/show/NCT01664936 |
Completed |
Memorial Sloan Kettering Cancer Center |
2018-04-03 |
| NCT01660776 |
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology |
https://ClinicalTrials.gov/show/NCT01660776 |
Completed |
Rennes University Hospital |
2017-10-02 |
| NCT01660568 |
Gemcitabine in NK/T Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01660568 |
Completed |
Samsung Medical Center |
2013-01-31 |
| NCT01639716 |
Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers |
https://ClinicalTrials.gov/show/NCT01639716 |
Completed |
Guler, Nil, M.D. |
2012-05-31 |
| NCT01623856 |
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients |
https://ClinicalTrials.gov/show/NCT01623856 |
Completed |
Children’s Oncology Group |
2012-06-30 |
| NCT01626547 |
Biosimilar Retacritâ„¢ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology |
https://ClinicalTrials.gov/show/NCT01626547 |
Completed |
Hospira, now a wholly owned subsidiary of Pfizer |
2012-12-31 |
| NCT01606605 |
Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01606605 |
Completed |
Samsung Medical Center |
2012-12-31 |
| NCT01584141 |
Study of Lymphoma in Asia |
https://ClinicalTrials.gov/show/NCT01584141 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01567722 |
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies |
https://ClinicalTrials.gov/show/NCT01567722 |
Recruiting |
AIDS Malignancy Consortium |
2020-06-30 |
| NCT01565447 |
Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study |
https://ClinicalTrials.gov/show/NCT01565447 |
Active, not recruiting |
Oregon Health and Science University |
2020-12-31 |
| NCT01563861 |
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01563861 |
Completed |
Southwest Oncology Group |
2008-06-01 |
| NCT01517581 |
Brown Fat Activity and White Fat Accumulation |
https://ClinicalTrials.gov/show/NCT01517581 |
Completed |
Children’s Hospital Los Angeles |
2011-09-30 |
| NCT01505712 |
Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial |
https://ClinicalTrials.gov/show/NCT01505712 |
Completed |
Eastern Cooperative Oncology Group |
2012-11-19 |
| NCT01490801 |
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT01490801 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01479387 |
Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan |
https://ClinicalTrials.gov/show/NCT01479387 |
Completed |
Bayer |
NA |
| NCT01478269 |
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen |
https://ClinicalTrials.gov/show/NCT01478269 |
Completed |
Fondazione Italiana Linfomi ONLUS |
2011-05-31 |
| NCT01478191 |
Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT |
https://ClinicalTrials.gov/show/NCT01478191 |
Completed |
Fondazione Italiana Linfomi ONLUS |
NA |
| NCT01469754 |
Longitudinal Survey Analysis in Lymphoma Survivors |
https://ClinicalTrials.gov/show/NCT01469754 |
Completed |
Weill Medical College of Cornell University |
2013-07-31 |
| NCT01460914 |
Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment |
https://ClinicalTrials.gov/show/NCT01460914 |
Active, not recruiting |
Dartmouth-Hitchcock Medical Center |
2050-09-30 |
| NCT01459224 |
MELT - MRI Evaluation of Lymphoma Treatment |
https://ClinicalTrials.gov/show/NCT01459224 |
Completed |
University College, London |
2014-09-30 |
| NCT01406782 |
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402 |
https://ClinicalTrials.gov/show/NCT01406782 |
Completed |
Eastern Cooperative Oncology Group |
2012-01-13 |
| NCT01402687 |
SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT) |
https://ClinicalTrials.gov/show/NCT01402687 |
Completed |
Dana-Farber Cancer Institute |
2013-02-28 |
| NCT01390597 |
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms |
https://ClinicalTrials.gov/show/NCT01390597 |
Completed |
Eastern Cooperative Oncology Group |
2011-08-28 |
| NCT01386697 |
DIBH Proton Planning |
https://ClinicalTrials.gov/show/NCT01386697 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2013-06-30 |
| NCT01381705 |
Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT01381705 |
Completed |
Eastern Cooperative Oncology Group |
2012-07-06 |
| NCT01367457 |
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus |
https://ClinicalTrials.gov/show/NCT01367457 |
Completed |
Pfizer |
2015-04-30 |
| NCT01366170 |
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01366170 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01366157 |
Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT01366157 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01341119 |
Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01341119 |
Completed |
Samsung Medical Center |
NA |
| NCT01340443 |
An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT01340443 |
Completed |
Hoffmann-La Roche |
2016-07-15 |
| NCT01319591 |
Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate |
https://ClinicalTrials.gov/show/NCT01319591 |
Completed |
Dana-Farber Cancer Institute |
2014-08-31 |
| NCT04419441 |
Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT04419441 |
Recruiting |
Ospedale Maggiore Di Trieste |
2020-06-30 |
| NCT04423549 |
Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT04423549 |
Recruiting |
Sun Yat-sen University |
2021-06-30 |
| NCT04423536 |
Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT04423536 |
Recruiting |
Sun Yat-sen University |
2021-06-30 |
| NCT04396119 |
Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study |
https://ClinicalTrials.gov/show/NCT04396119 |
Recruiting |
The Christie NHS Foundation Trust |
2020-08-31 |
| NCT04354402 |
Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL |
https://ClinicalTrials.gov/show/NCT04354402 |
Enrolling by invitation |
SymBio Pharmaceuticals |
2020-12-31 |
| NCT04319237 |
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes |
https://ClinicalTrials.gov/show/NCT04319237 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2022-06-30 |
| NCT04317313 |
Prediction of Outcome Using Pretreatment 18F-FDG PET/CT Radiomic Features in Diffuse Large B-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT04317313 |
Completed |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2018-09-30 |
| NCT04300998 |
Study of CAR-T Therapy in Older Patients |
https://ClinicalTrials.gov/show/NCT04300998 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-03-04 |
| NCT04298619 |
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission |
https://ClinicalTrials.gov/show/NCT04298619 |
Completed |
Federico II University |
2016-04-30 |
| NCT04263935 |
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma |
https://ClinicalTrials.gov/show/NCT04263935 |
Recruiting |
Henan Cancer Hospital |
2023-02-28 |
| NCT04107285 |
Looking at Brain Changes in People With Lymphoma Receiving CAR-T Therapy |
https://ClinicalTrials.gov/show/NCT04107285 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-09-30 |
| NCT04109872 |
Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results. |
https://ClinicalTrials.gov/show/NCT04109872 |
Recruiting |
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
2020-06-15 |
| NCT04088422 |
Cell Free DNA in Mature B-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT04088422 |
Recruiting |
Ruijin Hospital |
2024-04-30 |
| NCT04061850 |
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT04061850 |
Recruiting |
Samsung Medical Center |
2020-06-30 |
| NCT04055558 |
Lymphoproliferative Disorders During the Treatment of Childhood Acute Lymphoblastic Leukemia/Lymphoma |
https://ClinicalTrials.gov/show/NCT04055558 |
Recruiting |
Rabin Medical Center |
2019-12-18 |
| NCT04053439 |
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications |
https://ClinicalTrials.gov/show/NCT04053439 |
Recruiting |
Sunnybrook Health Sciences Centre |
2023-09-30 |
| NCT04048395 |
Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea |
https://ClinicalTrials.gov/show/NCT04048395 |
Recruiting |
Samsung Medical Center |
2020-04-30 |
| NCT02682667 |
Biospecimen Procurement for Experimental Transplantation and Immunology Branch Immunotherapy Protocols |
https://ClinicalTrials.gov/show/NCT02682667 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-12-01 |
| NCT04037189 |
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT04037189 |
Recruiting |
Rabin Medical Center |
2021-07-28 |
| NCT04034056 |
Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN) |
https://ClinicalTrials.gov/show/NCT04034056 |
Recruiting |
Hoffmann-La Roche |
2024-12-30 |
| NCT04028804 |
FLT PET: A Pilot Study in Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT04028804 |
Completed |
The Hospital for Sick Children |
2014-12-31 |
| NCT03977623 |
Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression |
https://ClinicalTrials.gov/show/NCT03977623 |
Recruiting |
Samsung Medical Center |
2022-02-28 |
| NCT03973164 |
The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma |
https://ClinicalTrials.gov/show/NCT03973164 |
Completed |
Guangxi Medical University |
2019-05-22 |
| NCT03969693 |
Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation |
https://ClinicalTrials.gov/show/NCT03969693 |
Recruiting |
Chang Gung Memorial Hospital |
2020-08-31 |
| NCT03942263 |
A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation |
https://ClinicalTrials.gov/show/NCT03942263 |
Recruiting |
Takeda |
2023-05-10 |
| NCT03932279 |
Characterization of the Microbiome in Cutaneous T Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03932279 |
Recruiting |
Northwestern University |
2020-12-31 |
| NCT03860376 |
Ex Vivo Drug Sensitivity Testing and Mutation Profiling |
https://ClinicalTrials.gov/show/NCT03860376 |
Recruiting |
Florida International University |
2022-12-15 |
| NCT03859544 |
Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular) |
https://ClinicalTrials.gov/show/NCT03859544 |
Recruiting |
Hospices Civils de Lyon |
2020-01-01 |
| NCT03742921 |
ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03742921 |
Recruiting |
Celgene |
2023-04-17 |
| NCT03729609 |
Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion “Untreated CD30-Positive Hodgkin’s Lymphoma” |
https://ClinicalTrials.gov/show/NCT03729609 |
Recruiting |
Takeda |
2022-05-31 |
| NCT03681938 |
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission? |
https://ClinicalTrials.gov/show/NCT03681938 |
Active, not recruiting |
Institut Paoli-Calmettes |
2019-07-28 |
| NCT03672084 |
Allo-HSCT as First-line Consolidation in High-risk PTCL |
https://ClinicalTrials.gov/show/NCT03672084 |
Recruiting |
Peking University People’s Hospital |
2021-08-31 |
| NCT03672682 |
SMOLY : Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma: Towards New Biomarkers? |
https://ClinicalTrials.gov/show/NCT03672682 |
Completed |
Rennes University Hospital |
2019-09-01 |
| NCT03664336 |
Refractory Diffuse Large B-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03664336 |
Completed |
Hospices Civils de Lyon |
2017-07-31 |
| NCT03664323 |
Anti-PD-1 and Chemotherapy for R/R Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT03664323 |
Completed |
Hospices Civils de Lyon |
2018-01-31 |
| NCT03663894 |
Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era |
https://ClinicalTrials.gov/show/NCT03663894 |
Completed |
Hospices Civils de Lyon |
2017-12-15 |
| NCT03647124 |
Non-Interventional Study in Patients With Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL) to Investigate the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden |
https://ClinicalTrials.gov/show/NCT03647124 |
Recruiting |
Celgene |
2026-12-31 |
| NCT03603847 |
Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma |
https://ClinicalTrials.gov/show/NCT03603847 |
Recruiting |
The Lymphoma Academic Research Organisation |
2023-07-31 |
| NCT03597685 |
Pesticide Associated Lymphomas: Expression of Treatment Resistance Genes |
https://ClinicalTrials.gov/show/NCT03597685 |
Completed |
University Hospital, Montpellier |
2018-12-31 |
| NCT03568929 |
Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT03568929 |
Recruiting |
Gilead Sciences |
2020-10-31 |
| NCT03546101 |
Early Detection of Epstein-Barr Virus Related Disease. |
https://ClinicalTrials.gov/show/NCT03546101 |
Active, not recruiting |
University of Aarhus |
2022-03-01 |
| NCT03535948 |
Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy |
https://ClinicalTrials.gov/show/NCT03535948 |
Active, not recruiting |
Central Hospital, Nancy, France |
2019-11-30 |
| NCT03525665 |
Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression |
https://ClinicalTrials.gov/show/NCT03525665 |
Completed |
Fondazione Italiana Linfomi ONLUS |
2019-12-30 |
| NCT03480087 |
Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma |
https://ClinicalTrials.gov/show/NCT03480087 |
Recruiting |
Azienda Ospedaliera Città della Salute e della Scienza di Torino |
2020-07-31 |
| NCT03476655 |
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India |
https://ClinicalTrials.gov/show/NCT03476655 |
Completed |
Johnson & Johnson Private Limited |
2019-05-14 |
| NCT03469921 |
Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 |
https://ClinicalTrials.gov/show/NCT03469921 |
Completed |
Institut Paoli-Calmettes |
2016-12-31 |
| NCT03436602 |
Personalized Risk Stratification Model of Follicular Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT03436602 |
Recruiting |
Oncology Institute of Southern Switzerland |
2021-03-31 |
| NCT03413644 |
Evaluation of ClearLLab Leukemia and Lymphoma Panels |
https://ClinicalTrials.gov/show/NCT03413644 |
Completed |
Beckman Coulter, Inc. |
2018-04-27 |
| NCT01264822 |
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori |
https://ClinicalTrials.gov/show/NCT01264822 |
Completed |
Eisai Inc. |
2016-02-29 |
| NCT01266668 |
The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL) |
https://ClinicalTrials.gov/show/NCT01266668 |
Completed |
Chonbuk National University Hospital |
2011-05-31 |
| NCT01248000 |
The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy |
https://ClinicalTrials.gov/show/NCT01248000 |
Completed |
Gruppo Italiano Studio Linfomi |
NA |
| NCT01230008 |
Radiotherapy in Primary Mediastinal Lymphoma |
https://ClinicalTrials.gov/show/NCT01230008 |
Completed |
Instituto Mexicano del Seguro Social |
2007-06-30 |
| NCT01228461 |
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT01228461 |
Completed |
Vanderbilt University Medical Center |
2012-01-31 |
| NCT01199562 |
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01199562 |
Completed |
City of Hope Medical Center |
2013-12-31 |
| NCT01196520 |
Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM) |
https://ClinicalTrials.gov/show/NCT01196520 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-12-31 |
| NCT01185886 |
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01185886 |
Active, not recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2021-06-30 |
| NCT01164696 |
A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin |
https://ClinicalTrials.gov/show/NCT01164696 |
Completed |
Bayer |
2009-05-31 |
| NCT01150643 |
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab |
https://ClinicalTrials.gov/show/NCT01150643 |
Completed |
Eastern Cooperative Oncology Group |
2011-01-06 |
| NCT01142674 |
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01142674 |
Completed |
Associazione Angela Serra per la ricerca sul cancro |
2016-07-31 |
| NCT01137825 |
Registry of Older Patients With Cancer |
https://ClinicalTrials.gov/show/NCT01137825 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2030-06-30 |
| NCT01137643 |
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT01137643 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2040-07-31 |
| NCT01131221 |
S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT01131221 |
Completed |
Southwest Oncology Group |
2011-09-30 |
| NCT01131208 |
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab |
https://ClinicalTrials.gov/show/NCT01131208 |
Completed |
Eastern Cooperative Oncology Group |
2010-08-21 |
| NCT01117142 |
A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01117142 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01111201 |
International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01111201 |
Completed |
Memorial Sloan Kettering Cancer Center |
2012-03-31 |
| NCT01110733 |
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry |
https://ClinicalTrials.gov/show/NCT01110733 |
Completed |
Acrotech Biopharma LLC |
2019-12-31 |
| NCT01057459 |
DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701 |
https://ClinicalTrials.gov/show/NCT01057459 |
Completed |
Alliance for Clinical Trials in Oncology |
2014-06-23 |
| NCT01043302 |
Multicenter Cross Sectional Study of Primary Intestine Lymphoma |
https://ClinicalTrials.gov/show/NCT01043302 |
Completed |
Samsung Medical Center |
2010-03-31 |
| NCT01000753 |
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT01000753 |
Active, not recruiting |
Children’s Oncology Group |
2007-06-01 |
| NCT01000558 |
SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT01000558 |
Completed |
Southwest Oncology Group |
2011-07-31 |
| NCT00993694 |
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone |
https://ClinicalTrials.gov/show/NCT00993694 |
Completed |
Vanderbilt University Medical Center |
2009-12-31 |
| NCT00985699 |
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00985699 |
Completed |
Southwest Oncology Group |
2014-06-30 |
| NCT00981097 |
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00981097 |
Completed |
AIDS Malignancy Consortium |
2013-06-30 |
| NCT00964821 |
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00964821 |
Completed |
City of Hope Medical Center |
2013-05-31 |
| NCT00956475 |
Quality of Life in Younger Leukemia and Lymphoma Survivors |
https://ClinicalTrials.gov/show/NCT00956475 |
Completed |
Case Comprehensive Cancer Center |
2010-09-30 |
| NCT00949741 |
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin’s Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT00949741 |
Completed |
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie |
2011-10-31 |
| NCT00944567 |
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT00944567 |
Completed |
International Extranodal Lymphoma Study Group (IELSG) |
2011-05-31 |
| NCT00933127 |
S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone |
https://ClinicalTrials.gov/show/NCT00933127 |
Completed |
Southwest Oncology Group |
2012-06-30 |
| NCT00928096 |
Breathing Adapted Radiotherapy for Mediastinal Lymphoma |
https://ClinicalTrials.gov/show/NCT00928096 |
Completed |
Rigshospitalet, Denmark |
2013-05-31 |
| NCT00920738 |
Metabolic Syndrome in Childhood Cancer Survivors |
https://ClinicalTrials.gov/show/NCT00920738 |
Completed |
University of Minnesota |
2010-07-31 |
| NCT00915096 |
Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT00915096 |
Completed |
Lymphoma Study Association |
2011-05-10 |
| NCT00923507 |
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) |
https://ClinicalTrials.gov/show/NCT00923507 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00903890 |
Cardiac Effects in Long-Term Survivors of Hodgkin’s and Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00903890 |
Active, not recruiting |
University of Rochester |
2018-11-30 |
| NCT00903812 |
IMPACT Non Hodgkins Lymphoma (NHL) Study |
https://ClinicalTrials.gov/show/NCT00903812 |
Completed |
Amgen |
2008-12-31 |
| NCT00902434 |
Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era |
https://ClinicalTrials.gov/show/NCT00902434 |
Completed |
Oncology Specialists, S.C. |
2011-02-28 |
| NCT00900250 |
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma |
https://ClinicalTrials.gov/show/NCT00900250 |
Completed |
Children’s Oncology Group |
2019-03-31 |
| NCT00900484 |
SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00900484 |
Completed |
Southwest Oncology Group |
2011-07-31 |
| NCT00898963 |
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496 |
https://ClinicalTrials.gov/show/NCT00898963 |
Completed |
Eastern Cooperative Oncology Group |
2011-12-21 |
| NCT00898872 |
SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial |
https://ClinicalTrials.gov/show/NCT00898872 |
Completed |
Southwest Oncology Group |
2011-07-31 |
| NCT00898755 |
Collecting and Storing Tissue From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898755 |
Completed |
Children’s Oncology Group |
2008-07-17 |
| NCT00898157 |
Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494 |
https://ClinicalTrials.gov/show/NCT00898157 |
Completed |
Eastern Cooperative Oncology Group |
2008-09-24 |
| NCT00897923 |
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00897923 |
Completed |
Mayo Clinic |
2012-02-10 |
| NCT00897325 |
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00897325 |
Completed |
Children’s Oncology Group |
2019-12-31 |
| NCT00896922 |
S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911 |
https://ClinicalTrials.gov/show/NCT00896922 |
Completed |
Southwest Oncology Group |
2009-10-31 |
| NCT00896662 |
Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 |
https://ClinicalTrials.gov/show/NCT00896662 |
Completed |
Vanderbilt-Ingram Cancer Center |
2007-10-31 |
| NCT00889278 |
Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00889278 |
Completed |
Dartmouth-Hitchcock Medical Center |
2012-03-01 |
| NCT03930043 |
A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin’s Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT03930043 |
Recruiting |
Ruijin Hospital |
2020-09-30 |
| NCT04183569 |
Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT04183569 |
Active, not recruiting |
University Hospital, Bordeaux |
2020-05-01 |
| NCT03797170 |
Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03797170 |
Recruiting |
University of Bologna |
2020-07-20 |
| NCT01369784 |
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01369784 |
Completed |
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea |
2011-03-31 |
| NCT00822432 |
Coproporphyrine Isomers and Methotrexate Elimination |
https://ClinicalTrials.gov/show/NCT00822432 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2011-08-31 |
| NCT03690895 |
Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy |
https://ClinicalTrials.gov/show/NCT03690895 |
Completed |
Fondation Ophtalmologique Adolphe de Rothschild |
2016-10-01 |
| NCT01483664 |
Communication Skills Intervention to Promote Transition Into Survivorship |
https://ClinicalTrials.gov/show/NCT01483664 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-11-30 |
| NCT01382082 |
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT01382082 |
Active, not recruiting |
University of Rochester |
2024-06-14 |
| NCT01563874 |
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins |
https://ClinicalTrials.gov/show/NCT01563874 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001686 |
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases |
https://ClinicalTrials.gov/show/NCT00001686 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT04213209 |
Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion “Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma” |
https://ClinicalTrials.gov/show/NCT04213209 |
Recruiting |
Takeda |
2022-12-31 |
| NCT04006561 |
Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost |
https://ClinicalTrials.gov/show/NCT04006561 |
Recruiting |
Chang Gung Memorial Hospital |
2022-02-28 |
| NCT04005703 |
Whole-body MRI in Pediatric Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT04005703 |
Active, not recruiting |
UMC Utrecht |
2016-12-31 |
| NCT03425591 |
A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT03425591 |
Recruiting |
Janssen-Cilag Ltd. |
2022-05-22 |
| NCT03065790 |
Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide |
https://ClinicalTrials.gov/show/NCT03065790 |
Active, not recruiting |
Abramson Cancer Center of the University of Pennsylvania |
2021-02-06 |
| NCT03288415 |
SMZL Molecular Prognostic Index |
https://ClinicalTrials.gov/show/NCT03288415 |
Active, not recruiting |
Oncology Institute of Southern Switzerland |
2020-06-30 |
| NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
https://ClinicalTrials.gov/show/NCT03050268 |
Recruiting |
St. Jude Children’s Research Hospital |
2037-03-31 |
| NCT03062072 |
Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients |
https://ClinicalTrials.gov/show/NCT03062072 |
Recruiting |
National Cancer Center, Korea |
2017-12-31 |
| NCT01087333 |
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment |
https://ClinicalTrials.gov/show/NCT01087333 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT04320992 |
A Multicenter Prospective Study of “High Risk” Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma |
https://ClinicalTrials.gov/show/NCT04320992 |
Recruiting |
Sun Yat-sen University |
2023-03-31 |
| NCT00744120 |
Lymphoma Follow-up |
https://ClinicalTrials.gov/show/NCT00744120 |
Completed |
National Institutes of Health Clinical Center (CC) |
2013-09-30 |
| NCT00741325 |
Long-Term Follow-up Study for Non-Hodgkin’s Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610). |
https://ClinicalTrials.gov/show/NCT00741325 |
Completed |
Sanofi |
2011-11-30 |
| NCT00731536 |
Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands |
https://ClinicalTrials.gov/show/NCT00731536 |
Completed |
Centocor Ortho Biotech Services, L.L.C. |
2010-04-30 |
| NCT00713882 |
Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors |
https://ClinicalTrials.gov/show/NCT00713882 |
Completed |
Weill Medical College of Cornell University |
2008-11-30 |
| NCT00712556 |
PET Study in Patients With Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00712556 |
Completed |
Vanderbilt-Ingram Cancer Center |
2009-03-31 |
| NCT00700258 |
Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] |
https://ClinicalTrials.gov/show/NCT00700258 |
Recruiting |
Pfizer |
2023-12-01 |
| NCT00695422 |
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials |
https://ClinicalTrials.gov/show/NCT00695422 |
Completed |
AIDS Malignancy Consortium |
2017-04-19 |
| NCT00685997 |
Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas |
https://ClinicalTrials.gov/show/NCT00685997 |
Completed |
UMC Utrecht |
2012-01-31 |
| NCT00582270 |
Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma |
https://ClinicalTrials.gov/show/NCT00582270 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-08-31 |
| NCT00581737 |
Cognitive Functioning and Quality of Life in CNS Lymphoma |
https://ClinicalTrials.gov/show/NCT00581737 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-08-31 |
| NCT00577538 |
Prevalence of Lymphoma in IBD |
https://ClinicalTrials.gov/show/NCT00577538 |
Completed |
Indiana University |
2008-10-31 |
| NCT00510315 |
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00510315 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-01-31 |
| NCT00487513 |
Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials |
https://ClinicalTrials.gov/show/NCT00487513 |
Completed |
Dana-Farber Cancer Institute |
2017-01-31 |
| NCT00461084 |
Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma |
https://ClinicalTrials.gov/show/NCT00461084 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-09-30 |
| NCT00440817 |
An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn’s Disease. |
https://ClinicalTrials.gov/show/NCT00440817 |
Completed |
Centocor Ortho Biotech Services, L.L.C. |
2006-08-31 |
| NCT00430053 |
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT00430053 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00416312 |
Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00416312 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2009-10-31 |
| NCT00398177 |
Clinical and Pathologic Studies in Non-Hodgkin’s Lymphoma and Hodgkin’s Disease |
https://ClinicalTrials.gov/show/NCT00398177 |
Recruiting |
Stanford University |
2099-01-31 |
| NCT00339963 |
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT00339963 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00341952 |
Interdisciplinary Case-Control Study of Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00341952 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00339638 |
Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1 |
https://ClinicalTrials.gov/show/NCT00339638 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00301314 |
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL). |
https://ClinicalTrials.gov/show/NCT00301314 |
Completed |
Royal Marsden NHS Foundation Trust |
NA |
| NCT00301301 |
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) |
https://ClinicalTrials.gov/show/NCT00301301 |
Completed |
Royal Marsden NHS Foundation Trust |
NA |
| NCT00301288 |
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL). |
https://ClinicalTrials.gov/show/NCT00301288 |
Completed |
Royal Marsden NHS Foundation Trust |
NA |
| NCT00286832 |
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV |
https://ClinicalTrials.gov/show/NCT00286832 |
Completed |
Copenhagen University Hospital at Herlev |
2011-01-31 |
| NCT00281814 |
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT00281814 |
Completed |
The Cleveland Clinic |
2008-12-31 |
| NCT00281801 |
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation |
https://ClinicalTrials.gov/show/NCT00281801 |
Completed |
Case Comprehensive Cancer Center |
2008-12-31 |
| NCT00240591 |
Patients With Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab |
https://ClinicalTrials.gov/show/NCT00240591 |
Completed |
GlaxoSmithKline |
2010-06-30 |
| NCT00240578 |
Patients With Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With Iodine I 131 Tositumomab |
https://ClinicalTrials.gov/show/NCT00240578 |
Completed |
GlaxoSmithKline |
2013-06-30 |
| NCT00226304 |
Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma |
https://ClinicalTrials.gov/show/NCT00226304 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00186147 |
Bone Marrow Grafting for Leukemia and Lymphoma |
https://ClinicalTrials.gov/show/NCT00186147 |
Enrolling by invitation |
Stanford University |
2069-12-31 |
| NCT00177268 |
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research |
https://ClinicalTrials.gov/show/NCT00177268 |
Recruiting |
University of Pittsburgh |
2027-01-31 |
| NCT00177190 |
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) |
https://ClinicalTrials.gov/show/NCT00177190 |
Completed |
University of Pittsburgh |
2005-01-31 |
| NCT00126477 |
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00126477 |
Completed |
Fred Hutchinson Cancer Research Center |
2007-04-30 |
| NCT00098566 |
Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00098566 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-06-30 |
| NCT00097565 |
An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00097565 |
Completed |
Genentech, Inc. |
2014-03-31 |
| NCT00091091 |
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00091091 |
Completed |
Children’s Oncology Group |
2011-06-27 |
| NCT00004875 |
Heparin or Enoxaparin in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00004875 |
Completed |
Northwestern University |
1999-03-31 |
| NCT00002563 |
SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin’s Disease |
https://ClinicalTrials.gov/show/NCT00002563 |
Completed |
Southwest Oncology Group |
2003-09-30 |
| NCT00006342 |
Genetic Study in Patients Receiving Treatment for Hodgkin’s Disease or Childhood Brain Tumor |
https://ClinicalTrials.gov/show/NCT00006342 |
Completed |
Duke University |
2000-09-30 |
| NCT00002485 |
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer |
https://ClinicalTrials.gov/show/NCT00002485 |
Completed |
Children’s Oncology Group |
2003-07-31 |
| NCT00068146 |
Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma |
https://ClinicalTrials.gov/show/NCT00068146 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00003863 |
Diagnostic Study of Patients With Aggressive Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00003863 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-05-31 |
| NCT00001301 |
Chronic and Late Effects of Non-Hodgkin’s Lymphoma and Its Treatment in Long Term Survivors |
https://ClinicalTrials.gov/show/NCT00001301 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00026910 |
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00026910 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00005881 |
Quality of Life in Children Treated for Cancer |
https://ClinicalTrials.gov/show/NCT00005881 |
Completed |
Children’s Oncology Group |
2003-03-31 |
| NCT00754117 |
Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET) |
https://ClinicalTrials.gov/show/NCT00754117 |
Completed |
Weill Medical College of Cornell University |
2010-12-31 |
| NCT00626496 |
Family Study of Lymphoproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00626496 |
Recruiting |
Mayo Clinic |
2025-12-31 |
| NCT00001571 |
A Pilot Study of Non-Hodgkin’s Lymphoma: Chemotherapy and Blood Levels of Organochlorines |
https://ClinicalTrials.gov/show/NCT00001571 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00006518 |
Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer |
https://ClinicalTrials.gov/show/NCT00006518 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001120 |
A Study of Patients With AIDS Syndrome |
https://ClinicalTrials.gov/show/NCT00001120 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00001582 |
Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer |
https://ClinicalTrials.gov/show/NCT00001582 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |